The COVID-19 pandemic has severely impacted healthcare services in Africa and Africa’s endoscopy devices market. For instance, an article published in the journal WJGE in November 2021 reported that a survey conducted in Africa reported a 13% reduction in endoscopic procedures during the beginning of the pandemic. However, the decline in COVID-19 cases and the resumption of services are expected to boost market growth, and the studied market is expected to recover in the coming years fully.
The factors driving the growth of the African endoscopy market include technological developments leading to enhanced endoscopy applications in different medical conditions such as cancerous and noncancerous tumors, esophagitis, gastritis, duodenitis, celiac disease, and Crohn's disease. For instance, in September 2022, Olympus Corporation launched VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals (HCPs) for endoscopic procedures across multiple medical disciplines. VISERA ELITE III is available in Africa including several other regions.
Also, the rising prevalence of gastrointestinal diseases such as gallstones, stomach ulcers, and gastritis where endoscopic procedures are commonly done to identify the cause of the disease, is increasing the usage of endoscopic procedures. An article published in the journal JGH, in June 2022, reported a high incidence of inflammatory bowel disease (IBD) in the African region. Endoscopy plays a fundamental role in the diagnosis, management, and treatment of inflammatory bowel disease; thus increasing IBD is driving the demand for endoscopic surgical devices in Africa.
Furthermore, the increasing incidence of cardiovascular diseases (CVDs) like coronary artery diseases in African countries is also increasing the demand for endoscopic devices. For instance, an article published by the journal EMHJ, in June 2022, reported that high-normal blood pressure (HNBP) has become associated with a two to three fold increase in the risk of developing hypertension, which gives rise to coronary artery diseases. The study published in the above-mentioned article stated that out of 13,983 adults aged between 18-59 years in Egypt 15.31% were associated with HNBP and 21.0% with hypertension, respectively. HNBP is an alarming risk factor among Egyptian adults because it is strongly associated with CVD risk, which may increase the demand for endoscopic devices for diagnosis and detection, thereby driving the growth of the studied market in Africa.
However, infections caused by few endoscopes, and the high cost of endoscopy procedures and equipment may slow down the market growth over the forecast period.
Africa Endoscopy Devices Market Trends
Gastroenterology Segment is Expected to Witness a Significant Growth Over the Forecast Period
The gastroenterology segment is expected to witness significant growth due to the rising prevalence of gastrointestinal diseases like ulcerative colitis, colorectum cancers, etc., requiring endoscopic surgical equipment. Gastroenterology refers to digestive system disorders, and colonoscopy is an endoscopic procedure used to examine the large and small intestines. Colonoscopy procedures are used to better diagnose tumors, colon polyps, ulcers, and inflamed or bleeding areas of the lower intestinal area.The high prevalence of colorectal cancer impacts the African region, and colonoscopy to detect these cancers is driving demand for this market. For instance, Globocan in 2020 reported that in Africa, 323,000 cases of rectum cancers were recorded, and this number is expected to increase to 534,000 by 2040. The same source also reported that the region recorded about 366,000 cases of colon cancer in 2020 in Africa, and the number is expected to increase to 626,000 by 2040.
Also, a high number of gastrointestinal disease and stomach cancer cases are fueling the market. For instance, an article published in the journal WJG, in March 2022, reported that stomach cancer is one of the most lethal malignant tumors, with a five-year survival rate of around 20%, and the prevalence was estimated to be 77.6% in South Africa.
Egypt is Expected to Witness a Significant Growth Over the Forecast Period
Egypt is expected to witness significant growth owing to advanced endoscopy devices, high incidences of chronic diseases, and increased awareness. Also, improved quality of care is triggering market growth for endoscopy devices in Egypt. For instance, in January 2022, Pentax Medical Europe launched a new ultra-fast endoscope drying and storage solution, the Plasma TYPHOON, in African countries. It is designed to improve productivity and traceability, and this premium model further advances endoscope reprocessing to enhance patient safety.The high prevalence of colon and rectum cancer in Egypt drives the demand for endoscopy devices. For instance, Globocan reported that Egypt had 15,000 rectum cancer cases in the year 2020, and this number is expected to grow by 67.5% in 2040, reaching 25,000 thousand by the year 2040. Similarly, 34,000 colon cancer cases were reported in Egypt in 2020, which is expected to increase by 59,000 thousand in 2040, growing at 74.1%.
Similarly, in May 2022, Ibnsina Pharma acquired EI Shorouk Hospital, Egypt. This acquisition was to diversify the strategies in the healthcare sector with the aim to add improve and equip all the healthcare services in the hospital that also included the endoscopic unit. Thus, such mergers, acquisitions, and partnerships are leading to provide better endoscopic services to the patients of the country, thereby driving the growth of the studied market.
Africa Endoscopy Devices Market Competitor Analysis
The African endoscopy devices market is moderately competitive due to the presence of a few global players. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known as Braun Melsungen AG, Boston Scientific Corporation, Fujifilm Holdings Corporation, Johnson & Johnson, Karl Storz GmbH & Co. KG, Medtronic PLC, Olympus Medical Systems Corporation, Richard Wolf GmbH, Steris Corporation, and Stryker Corporation.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- B Braun Melsungen AG
- Boston Scientific Corporation
- Fujifilm Holdings Corporation
- Johnson & Johnson
- Karl Storz GmbH & Co. KG
- Medtronic PLC
- Olympus Medical Systems Corporation
- Richard Wolf GmbH
- Steris Corporation
- Stryker Corporation
Methodology
LOADING...